Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B0KP
|
||||
Former ID |
DNC004660
|
||||
Drug Name |
1-Oxazolo[4,5-b]pyridin-2-yl-octadec-9-yn-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527476] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H34N2O2
|
||||
Canonical SMILES |
CCCCCCCCC#CCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2
|
||||
InChI |
1S/C24H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-21(27)24-26-23-22(28-24)19-17-20-25-23/h17,19-20H,2-8,11-16,18H2,1H3
|
||||
InChIKey |
DBMKKVSGBYKSFI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [527476] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.